Broadpoint Capital Starts Magellan Health (MGLN) at Buy
More News related to MGLN
- Magellan Health Services to Release 2009 Financial Guidance on December 17, 2008
- Magellan Health Services Presents at National Federation of Families Conference
- Former First Lady Rosalynn Carter Addresses Magellan Health Services Clinical Leadership Team
- Magellan Expands Knowledge on Virtual Reality Therapy for Treatment of Veterans with Posttraumatic Stress Disorder
- Magellan Health Services to Present at Credit Suisse 2008 Healthcare Conference
More News related to New Coverage
- Citi Initiates Coverage on US Soft Drink Makers
- William Blair Initiates Coverage on Data Networking Stocks
- Caris Starts Coverage on Ariba (ARBA), Concur (CNQR), salesforce.com (CRM), Taleo (TLEO)
- Oppenheimer Initiates Coverage on ViroPharma (VPHM)
- Oppenheimer Initiates Coverage on Cadence Pharmaceuticals (CADX) with an Outperform
Broadpoint Capital initiates coverage on Magellan Health (Nasdaq: MGLN) with a Buy rating and $50 price target.
Magellan Health Services, Inc. provides managed behavioral healthcare, radiology benefits management, and pharmaceutical management services in the United States.
Related Categories
New CoverageStocks Mentioned
+2.06Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
